← Back to Patent Explorer
US3689646A Expired / Lapsed US ⏱️ 0.0 years remaining

Antimutagenic treatment of bacteria

Assignee: University of Pennsylvania
•
Filing: 1969-09-04
•
Granted: 1972-09-05
•
Expires: 1989-09-04
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract This invention is concerned with a method of killing bacteria with a bactericide so as not to inherently produce bacteria strains resistant to the bactericide. In the method of this invention, the bactericide is utilized along with an effective amount of an antimutagenic agent such as spermine, spermidine, quinacrine hydrochloride, chlorpromazine, promethazine, levomepromazine, cyclobenzaprine, 3-chlorodibenzocycloheptene, protriptyline, amitriptyline, azepine hydrochloride and imipramine.

Inventors

  • 👤 Manasseh G Sevag

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 03:08
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/63; A61K31/635; A61K31/33; A61K31/395; A61K31/435; A61K31/47; A61K31/54; A61K31/55; A61K31/65; A61K31/70

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 53 words
A composition for killing bacteria by physical contact therewith consisting essentially of (1) an effective amount of a bactericidal component selected from the class consisting of sulfathiazole, chloromycetin, streptomycin, penicillin, erythromycin, tetracycline, chloramphenicol and novobiocin, and (2) an amount in the range of 20- 200 micrograms of quinacrine hydrochloride, in sterile aqueous solution.
Claim 2
Dependent Claim 32 words
A composition for killing bacteria by physical contact, comprising a sterile aqueous solution of about 10- 100 micrograms per milliliter or streptomycin and about 20- 200 micrograms per milliliter of quinacrine hydrochloride.
Claim 3
Dependent Claim 32 words
A composition for killing bacteria by physical contact, comprising a sterile aqueous solution of about 0.01- 1.0 unit of penicillin per milliliter and about 20- 200 micrograms per milliliter of quinacrine hydrochloride.
Claim 4
Dependent Claim 32 words
A composition for killing bacteria by physical contact comprising a sterile aqueous solution of about 0.1- 10 micrograms per milliliter of novobiocin and about 20- 200 micrograms per milliliter of quinacrine hydrochloride.
Claim 5
Dependent Claim 30 words
A composition for killing bacteria by physical contact comprising a sterile aqueous solution of about 0.1-10.0 micrograms per milliliter of erythromycin and about 20-200 micrograms per milliliter of quinacrine hydrochloride.
Claim 6
Dependent Claim 32 words
A composition for killing bacteria by physical contact comprising a sterile aqueous solution of about 0.1- 10.0 micrograms per milliliter of tetracycline and about 20- 200 micrograms per milliliter of quinacrine hydrochloride.
Claim 7
Dependent Claim 32 words
A composition for killing bacteria by physical contact comprising a sterile aqueous solution of about 0.1- 10 micrograms per milliliter of chloramphenicol and about 20- 200 micrograms per milliliter of quinacrine hydrochloride.
Claim 8
Dependent Claim 32 words
A composition for killing bacteria by physical contact comprising a sterile aqueous solution of about 0.1- 100 micrograms per milliliter of sulfathiazole and about 20- 200 micrograms per milliliter of quinacrine hydrochloride.

References Cited (Backward Citations)

US2579185A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1975-09-05 1976-03-06 1976-09-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1979-09-05 1980-03-06 1980-09-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1983-09-05 1984-03-06 1984-09-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag